Yulun Wang, Ph.D., Chairman & Chief Executive Officer, launched his career at the intersection of healthcare and technology with the founding of Computer Motion, Inc. and the invention of AESOP, the first FDA-cleared surgical robot. Under his leadership, Computer Motion went public in 1997 and later merged with Intuitive Surgical to forge the multi-billion dollar surgical robotics industry. In 2002, Dr. Wang founded InTouch Health which has been recognized as one of the fastest growing healthcare and technology companies by the likes of Inc. 500 and Deloitte 500. Dr. Wang has received multiple entrepreneurship and leadership awards and was elected to the prestigious ranks of the National Academy of Engineering in 2011. Author to more than 50 publications and 100 registered patents, he is a member of the University of California, Santa Barbara's Electrical and Computer Engineering and Mechanical Engineering Advisory Board, the Hoag Memorial Hospital Presbyterian Board of Directors, and the American Telemedicine Association (ATA) Board of Directors, where he also serves as an officer. Frequently invited to speak at noteworthy meetings and events, Dr. Wang has appeared on the Today Show, CNN and other nationally televised news programs. He received his Ph.D. in Electrical Engineering specializing in Robotics from the University of California, Santa Barbara.
John Glaser, Ph.D. currently serves as chief executive officer (CEO) of the Health Services Business Unit of Siemens Healthcare, where he is responsible for heading Siemens' global healthcare IT business.
Prior to joining Siemens, Dr. Glaser was Vice-President and Chief Information Officer, Partners HealthCare, Inc. Previously, he was Vice-President, Information Systems at Brigham and Women's Hospital.
Dr. Glaser was the founding chairman of the College of Healthcare Information Management Executives (CHIME), and is the former chairman of the eHealth Initiative Board and the Board of the National Alliance for Health Information Technology. He is a former Senior Advisor to the Office of the National Coordinator for Health Information Technology (ONC). He is also past president of the Healthcare Information & Management Systems Society (HIMSS), and is a fellow of HIMSS, CHIME, and the American College of Medical Informatics, where he previously served on the board.
Dr. Glaser has published more than 150 articles and three books on the strategic application of information technology in healthcare. He also gives approximately 100 industry speeches each year. Dr. Glaser holds a Ph.D. in Healthcare Information Systems from the University of Minnesota.
Michael Gross is the Managing Director of Beringea, LLC, a global private equity and investment banking firm. Mr. Gross is responsible for investment sourcing, deal execution and portfolio management, specifically for the InvestMichigan! Growth Capital Fund. He focuses on the healthcare and life sciences sectors, and has expertise in medical devices, diagnostics, life science research, drug delivery, health care providers and outsourced services. Mr. Gross has authored numerous articles and research papers and frequently speaks to health care and manufacturing audiences on a variety of trends and emerging industry themes. He serves as a board director for Beringea portfolio companies gloStream, Delphinus Medical Technologies and InTouch Health, and is a board observer for Pioneer Surgical Technology and Sakti3.
Prior to joining Beringea, Mr. Gross was a vice president of investment banking with P&M Corporate Finance (PMCF). While at PMCF, he led M&A transactions and capital raises for companies in the life sciences, health care and outsourced business services sectors. Before working at PMCF, Mr. Gross worked in the investment banking group at Stout Risius Ross, Inc. He earned a BA in finance from Michigan State University.
David W. Jahns is a General Partner at Galen Partners. Prior to joining Galen in 1993, Mr. Jahns was a financial Analyst in Smith Barney's Corporate Finance Division for two years. His responsibilities included financial analysis and preparation of proposals for clients on a variety of corporate finance and merger and acquisition-related transactions. He also assisted in the marketing of public offerings, performing due diligence and cash flow analyses.
Mr. Jahns earned a BA in Political Science and economics from Colgate University, where he graduated Phi Beta Kappa, and an MBA from the J. L. Kellogg Graduate School of Business, where he specialized in Health Services Management. Mr. Jahns currently serves on the boards of DAOU Systems, Inc., Specialized Health Products International, Inc. and several of Galen's privately held portfolio companies.
Anthony "Tony" Radaich has 38 years of public accounting experience at Arthur Andersen, Ernst & Young, and CNM LLP. Mr. Radaich is currently the Executive Director with CNM, an accounting and consulting firm based in Woodland Hills, California. Prior to joining CNM, Mr. Radaich was an audit and business advisory partner with Ernst & Young and Arthur Andersen. While at Ernst & Young, he was responsible for venture capital relationships in the Greater Los Angeles area and also managed the Entrepreneur of the Year program. At Arthur Andersen, he served as the managing partner of the Woodland Hills office.
Mr. Radaich specializes in providing services to early stage, venture funded companies and middle market enterprises focused on medical and health science technology and communications. Mr. Radaich has provided auditing services to numerous successful companies in the Santa Barbara area including Circon Corporation, Wavefront Technologies, Inamed, Transoft Technologies, Citrix On-Line, QAD, Software.com, Greenhills Software, and Digital Instruments.
Mr. Radaich earned a BS with honors in accounting from California State Polytechnic University, Pomona. He is a Certified Public Accountant and a member of the executive board of the AeA.
Robert L. Skinner is a managing partner and co-founder of Twenty One East Victoria Investments, an investment firm focused on high-quality investment opportunities created by the Central Coast's growing technology industry, fueled largely by the highly regarded engineering and applied physics programs at the University of California, Santa Barbara. Mr. Skinner is a managing member of Towbes Capital Partners, and Executive Vice President and General Counsel of the Towbes Group Inc. Mr. Skinner is also the Chief Executive Officer of Agility Capital, LLC, a venture-debt fund that he co-founded in 1999. Mr. Skinner serves on the board of directors of Montecito Bank & Trust and Barrister Executive Suites, Inc. Prior to moving to Santa Barbara, Mr. Skinner was an attorney with the international law firm of White & Case in its Los Angeles and New York offices where he represented such clients as The Tokai Bank, Swiss Bank and Wells Fargo Bank. Mr. Skinner earned his Juris Doctorate from the University of Southern California.
Alexander "Sandy" Spiro, Jr. is co-founder and Senior Managing Director of Beringea. His responsibilities include portfolio investment management, fund raising, and group business development.
Mr. Spiro serves on the investment committees of InvestCare Partners and Global Rights Fund II. He is also active on several InvestCare investee companies' boards of directors, including MedVantx and Fisher Consulting, Inc. In addition to his responsibilities in the U.S., Mr. Spiro assisted in managing the London office of Beringea and serves as a director of Proven VCT and Proven Media VCT, both publicly listed on the London Stock Exchange.
Prior to joining Beringea, Mr. Spiro owned and operated two profitable skilled nursing facilities. He also spent more than 30 years in the healthcare industry as a highly successful healthcare administrator and entrepreneur. In 1993, Mr. Spiro was a finalist in the healthcare division for the Ernst & Young Entrepreneur of the Year award. In addition, he has had a wide range of business experiences, from computer integration to the development of a web site for healthcare organizations and facilities. Mr. Spiro earned a business degree from Schoolcraft College (1972) and is a veteran of the U.S. Navy, serving during the Vietnam War.
Bill Williams is a Special Venture Partner with Galen Partners. Galen Partners is one of the largest and most influential private equity investment firms focused solely on the healthcare industry.
He was President of Pyxis Corporation from 1996-1998. He joined Pyxis in 1988 as the second employee and its Vice President of Marketing and Sales. Later he would serve as Vice President of Sales & Sales Operations, Senior Vice President and Executive Vice President. He was foundational to the early stage market research, strategic planning, organizational structure, product development, M&A activity and capital formation of the company. He was a central figure in the development of the Pyxis value-based corporate culture and service-oriented sales strategies. He played a prominent role in guiding Pyxis to one of the nation's most successful public offerings in 1992, and eventually a billion dollar merger with Cardinal Health, an S&P 500 company, in 1996.
Prior to joining Pyxis, Mr. Williams had twenty years of healthcare experience that included staff and line management positions with Johnson & Johnson, Zimmer USA, Howmedica and DePuy, Inc. During those years he was involved with the development and market introduction of numerous medical devices, capital goods, services and software applications to the healthcare marketplace.
He is the founder and President of Faranhyll Foundation, Inc., whose charter is to foster value-based leadership in corporate life. He is a frequent speaker and seminar leader addressing such topics as leadership, mentoring, marketing & sales strategies, and corporate culture development. He is the author of the non-fiction book, Wrestling with Destiny. Mr. Williams graduated from the University of Missouri in 1970 with a Bachelor of Arts degree.
December 5, 2013Awakening To Miracles
In the holiday season, we can celebrate the miracles made possible by telemedicine.
November 20, 2013Mobile App Clarity
The FDA rules that most mobile apps fall far short of medical device status.